Volume 76, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Although vector control and ivermectin chemotherapy have led to a dramatic reduction in the incidence of river blindness (onchocerciasis), there is a consensus that additional control tools are required to sustain and extend this success. The recognition of endosymbiotic bacteria () in filariae and their targeting by antibiotics constitutes the most significant and practicable opportunity for a macrofilaricidal therapy in the short-to-medium-term. Using in cattle, an analog of human onchocerciasis, we have previously shown that oxytetracycline is macrofilaricidal, and protective immunity exists naturally in a subset of animals termed putatively immune. Here, we report that although 24 weeks of weekly oxytetracycline treatment eliminated adult worms, cured animals remained susceptible to re-infection by natural challenge when compared with putatively immune cattle. However, their susceptibility was not significantly different from that of concurrently exposed, heavily infected animals. Thus, cattle cured by oxytetracycline are neither hypo-susceptible nor hyper-susceptible.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Dadzie Y, Neira M, Hopkins D, 2003. Final report of the conference on the eradicability of onchocerciasis. Filaria J 2 : 2. [Google Scholar]
  2. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van OG, Boatin BA, Habbema JD, 2002. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ 80 : 384–391. [Google Scholar]
  3. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, 1999. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients. Trans R Soc Trop Med Hyg 93 : 189–194. [Google Scholar]
  4. Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, Bissan Y, Renz A, Yameogo L, Remme JH, Habbema JD, 2003. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J 2 : 8. [Google Scholar]
  5. Hopkins AD, 2005. Ivermectin and onchocerciasis: is it all solved? Eye 19 : 1057–1066. [Google Scholar]
  6. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M, 1997. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350 : 18–22. [Google Scholar]
  7. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, Lazdins-Helds JK, Ardrey AE, Addy ET, Quartey BT, Ahmed K, Boatin BA, Soumbey-Alley EW, 2004. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98 : 231–249. [Google Scholar]
  8. Molyneux DH, 2005. Onchocerciasis control and elimination: coming of age in resource-constrained health systems. Trends Parasitol 21 : 525–529. [Google Scholar]
  9. Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke NJ, Plaisier AP, Remme JH, Lazdins J, Borsboom GJ, Habbema JD, 2001. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health 1 : 12. [Google Scholar]
  10. Cook JA, Steel C, Ottesen EA, 2001. Towards a vaccine for onchocerciasis. Trends Parasitol 17 : 555–558. [Google Scholar]
  11. McCall JW, Jun JJ, Bandi C, 1999. Wolbachia and the antifilarial properties of tetracycline: an untold story. Ital J Zool (Modena) 66 : 7–10. [Google Scholar]
  12. Hoerauf A, Nissen-Pähle K, Schmetz C, Henkle-Dührsen K, Blaxter ML, Büttner DW, Gallin MY, Al-Qaoud KM, Lucius R, Fleischer B, 1999. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest 103 : 11–18. [Google Scholar]
  13. Langworthy NG, Renz A, Mackenstedt U, Henkle-Dührsen K, de Bronsvoort MB, Tanya VN, Donnelly MJ, Trees AJ, 2000. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc R Soc Lond B Biol Sci 267 : 1063–1069. [Google Scholar]
  14. Xie H, Bain O, Williams SA, 1994. Molecular phylogenetic studies on filarial parasites based on 5S ribosomal spacer sequences. Parasite 1 : 141–151. [Google Scholar]
  15. Trees AJ, Wood VL, Bronsvoort M, Renz A, Tanya VN, 1998. Animal models: Onchocerca ochengi and the development of chemotherapeutic and chemoprophylactic agents for onchocerciasis. Ann Trop Med Parasitol 92 (Suppl 1): S175–S179. [Google Scholar]
  16. Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, Büttner DW, 2000. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355 : 1242–1243. [Google Scholar]
  17. Debrah AY, Mand S, Marfo-Debrekyei Y, Larbi J, Adjei O, Hoerauf A, 2006. Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Filaria J 5 : 1. [Google Scholar]
  18. Taylor MJ, Bandi C, Hoerauf A, 2005. Wolbachia bacterial endosymbionts of filarial nematodes. Adv Parasitol 60 : 245–284. [Google Scholar]
  19. Bergquist NR, Leonardo LR, Mitchell GF, 2005. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21 : 112–117. [Google Scholar]
  20. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, Loukas A, 2006. New technologies for the control of human hookworm infection. Trends Parasitol 22 : 327–331. [Google Scholar]
  21. Tchakouté VL, Graham SP, Jensen SA, Makepeace BL, Nfon CK, Njongmeta LM, Lustigman S, Enyong PA, Tanya VN, Bianco AE, Trees AJ, 2006. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proc Natl Acad Sci U S A 103 : 5971–5976. [Google Scholar]
  22. Soboslay PT, Lüder CGK, Hoffmann WH, Michaelis I, Helling G, Heuschkel C, Dreweck CM, Blanke CH, Pritze S, Banla M, Schulz-Key H, 1994. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol 96 : 238–244. [Google Scholar]
  23. Duke BO, 1968. Reinfections with Onchocerca volvulus in cured patients exposed to continuing transmission. Bull World Health Organ 39 : 307–309. [Google Scholar]
  24. Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Büttner DW, Ceciliani F, Geisinger F, Hochrein H, Ernst M, Wagner H, Bandi C, Hoerauf A, 2004. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol 173 : 437–445. [Google Scholar]
  25. Wahl G, Enyong P, Ngosso A, Schibel JM, Moyou R, Tubbesing H, Ekale D, Renz A, 1998. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man. Parasitology 116 : 349–362. [Google Scholar]
  26. Renz A, Trees AJ, Achukwi D, Edwards G, Wahl G, 1995. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle. Trop Med Parasitol 46 : 31–37. [Google Scholar]
  27. Gilbert J, Nfon CK, Makepeace BL, Njongmeta LM, Hastings IM, Pfarr KM, Renz A, Tanya VN, Trees AJ, 2005. Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J Infect Dis 192 : 1483–1493. [Google Scholar]
  28. Graham SP, Trees AJ, Collins RA, Moore DM, Guy FM, Taylor MJ, Bianco AE, 2001. Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis. Infect Immun 69 : 4313–4319. [Google Scholar]
  29. Subrahmanyam D, 1987. Antifilarials and their mode of action. Ciba Found Symp 127 : 246–264. [Google Scholar]
  30. Cox FE, 1992. Interactions between chemotherapy and immunity in bovine theileriosis. Parasitology 105 (Suppl): S79–S84. [Google Scholar]
  31. Mutapi F, Ndhlovu PD, Hagan P, Spicer JT, Mduluza T, Turner CM, Chandiwana SK, Woolhouse ME, 1998. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 178 : 289–293. [Google Scholar]
  32. Doetze A, Satoguina J, Burchard G, Rau T, Loliger C, Fleischer B, Hoerauf A, 2000. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 12 : 623–630. [Google Scholar]
  33. Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, Maizels RM, 2005. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174 : 4924–4933. [Google Scholar]
  34. Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB, 1991. Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis 164 : 581–587. [Google Scholar]
  35. Akuffo H, Maasho K, Lavebratt C, Engstrom K, Britton S, 1996. Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectin. Clin Exp Immunol 103 : 244–252. [Google Scholar]
  36. Plaisier AP, Van Oortmarssen GJ, Habbema JD, Remme J, Alley ES, 1990. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed 31 : 43–56. [Google Scholar]
  37. Duerr HP, Dietz K, Schulz-Key H, Büttner DW, Eichner M, 2003. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans R Soc Trop Med Hyg 97 : 242–250. [Google Scholar]
  38. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE, 2004. Helminth parasites: masters of regulation. Immunol Rev 201 : 89–116. [Google Scholar]
  39. Dupré L, Hervé M, Schacht AM, Capron A, Riveau G, 1999. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment. J Infect Dis 180 : 454–463. [Google Scholar]
  40. Njongmeta LM, Nfon CK, Gilbert J, Makepeace BL, Tanya VN, Trees AJ, 2004. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal. Int J Parasitol 34 : 1069–1074. [Google Scholar]
  41. Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW, 2001. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357 : 1415–1416. [Google Scholar]
  42. Srivastava K, Misra-Bhattacharya S, 2003. Tetracycline, a tool for transmission blocking of Brugia malayi in Mastomys coucha. Curr Sci 85 : 588–589. [Google Scholar]
  43. Brouqui P, Fournier PE, Raoult D, 2001. Doxycycline and eradication of microfilaremia in patients with loiasis. Emerg Infect Dis 7 : 604–605. [Google Scholar]

Data & Media loading...

  • Received : 27 Jul 2006
  • Accepted : 17 Sep 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error